Blue Sail Medical Co.Ltd(002382)
Independent director’s decision on reappointment of the company’s audit institution in 2022
Prior approval of
In accordance with the rules for independent directors of listed companies, the Blue Sail Medical Co.Ltd(002382) articles of association, the independent director system and other relevant provisions, as an independent director of Blue Sail Medical Co.Ltd(002382) (hereinafter referred to as the “company”), I have conducted a pre review on the renewal of the company’s audit institution in 2022, communicated and discussed with the company’s directors and management, and issued the following pre approval opinions:
We believe that Ernst & Young Huaming Certified Public Accountants (special general partnership) (hereinafter referred to as “Ernst & Young Huaming”) strictly followed the laws, regulations and relevant policies related to financial audit such as the independent auditing standards for Chinese certified public accountants during its tenure as the company’s audit institution in 2021, was diligent and conscientious, followed the independent, objective and impartial practice standards, and showed good professional ethics and professional quality, The responsibilities and obligations agreed by both parties have been well fulfilled. Therefore, it is agreed to submit the renewal of an Yonghua Ming as the audit institution of the company in 2022 to the board of directors for deliberation.
(there is no text below, and the signature page is attached)
(there is no text on this page, which is the signature page of Blue Sail Medical Co.Ltd(002382) independent director’s prior approval opinions on the renewal of the company’s audit institution in 2022) signature of independent director:
Liu Shengjun, Dong Shukui, Gong bengao
April 1, 2002
